[ad_1]

Lead researcher on the project, Professor Owen Sansom, director of the Cancer Research UK Scotland Institute and the University of Glasgow, said: “Because NPM1 isn’t essential for normal adult tissue health, blocking it could be a safe way to treat certain cancers, like some hard-to-treat bowel and liver cancers.
[ad_2]
Source link
